Clot-busting drugs are the main treatment for stroke, but they have often not been recommended for people who have an aneurysm in their brains that has not ruptured. An aneurysm is a bulge in the wall ...
Stroke patients receiving thrombolysis do not appear to be an increased risk of symptomatic intracerebral hemorrhage (sICH) if they are taking direct oral anticoagulants (DOACs), a new study has found ...
HELSINKI, Finland—Adding IV tirofiban improves functional outcomes among patients undergoing systemic thrombolysis for acute ischemic stroke within 4.5 hours of symptom onset, results from the ...
Reteplase appears to be another safe and effective thrombolytic option for the treatment of acute ischemic stroke, according to results from the randomized RAISE trial. When given within the first 4.5 ...
A study evaluating a new approach using a combination of two thrombolytics designed to reduce bleeding risk in patients with acute ischemic stroke has not shown any benefit on the primary outcome of ...
Thrombolytic drugs are the main treatment for stroke, but they have often not been recommended for people who have an aneurysm in their brains that has not ruptured. A new study (“Risk of Aneurysm ...
A research team led by Professor Shen Jiangang from the School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong (HKUMed) reveals that Angong Niuhuang Wan (AGNHW), a classical ...
Hoffmann-La Roche Limited (Roche Canada) is proud to announce that Health Canada has granted market authorization for TNKase® ...
Please provide your email address to receive an email when new articles are posted on . Race, ethnicity and health insurance status all appeared to impact receipt of treatment for ischemic stroke ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback